Urinary excretion of aquaporin-2 water channel exaggerated dependent upon vasopressin in congestive heart failure.
about
Aquaporins in Urinary Extracellular Vesicles (Exosomes)Urine Aquaporin-2: A Promising Marker of Response to the Arginine Vasopressin Type-2 Antagonist, Tolvaptan in Patients with Congestive Heart FailureHyponatremia Associated with Heart Failure: Pathological Role of Vasopressin-Dependent Impaired Water ExcretionAVP-induced increase in AQP2 and p-AQP2 is blunted in heart failure during cardiac remodeling and is associated with decreased AT1R abundance in rat kidneyRationale and design of the treatment of hyponatremia based on lixivaptan in NYHA class III/IV cardiac patient evaluation (THE BALANCE) study.Vasopressin receptor antagonists in the management of acute heart failure.Prospects for urinary proteomics: exosomes as a source of urinary biomarkers.Adaptation of renal function in heart failure.Vasopressin dysregulation and hyponatremia in hospitalized patients.Role of vasopressin and vasopressin receptor antagonists in type I cardiorenal syndrome.Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists?Urinary exosomes and proteomics.Acid-base and electrolyte abnormalities in heart failure: pathophysiology and implications.Elevation of arginine vasopressin levels following loop diuretic therapy as a prognostic indicator in heart failureOutcomes of correcting hyponatremia in patients with myocardial infarction.Hyponatremia and heart failure--pathophysiology and implications.Increased urinary aquaporin-2 excretion in response to furosemide in patients with chronic heart failure.Is Exaggerated Release of Arginine Vasopressin an Endocrine Disorder? Pathophysiology and Treatment.Aquaporins in Cardiovascular System.Low aquaporin-2 excretion in the nephrotic syndrome: an escape from the vasopressin regulating effect
P2860
Q26744354-E4960055-DE7C-4A6C-8313-8FA8B2517528Q26771172-35E51240-7D70-4CE4-9C6E-6D7989A6F49DQ26799518-5ADD279B-3F0E-4342-972C-81A801824337Q28543216-1FB15E5C-073F-4F1B-A23A-FD74BBD652F8Q33712822-6F4E3C3A-D614-4F7E-8C22-073926CDAC5DQ36145836-A64EC319-B437-4C4D-A38B-F20B74042AFCQ36164076-3357DB6C-D433-4EB7-AFC0-8B443D3E4860Q36627825-AAE50760-E93F-4BFC-9078-412B13E8B2BCQ36915779-CF669C01-7354-4C74-8550-A887DB3CCC70Q37322844-A5281DE1-7EBA-4276-B559-AADA602E5819Q37806693-57D6A331-C47A-4D07-87E4-275DF410BC5CQ37872261-2C1B2EDE-1D04-4868-9FFA-434837C1FFD1Q38395162-E72E0838-6132-4D43-A368-012F256EB79FQ40508135-61201DCD-0F31-42DC-B6BB-D54BAD25EFEFQ44335751-C9B12B1B-2AD8-4C4A-AF84-D6F132962845Q44914411-050C7263-EBF0-4321-8657-A2D4667BFDFFQ46933025-20210EC8-1F14-420C-9C2B-C0C5F39E1A46Q47125977-9811D1AA-09CC-4B13-B48C-DA5A110D6F01Q48281924-A78FC239-A07F-42B3-8A3E-41D55CA4229BQ58544242-5BA7D4D6-FFE8-48FE-B932-8EBF7A500CFD
P2860
Urinary excretion of aquaporin-2 water channel exaggerated dependent upon vasopressin in congestive heart failure.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Urinary excretion of aquaporin ...... n in congestive heart failure.
@en
Urinary excretion of aquaporin ...... n in congestive heart failure.
@nl
type
label
Urinary excretion of aquaporin ...... n in congestive heart failure.
@en
Urinary excretion of aquaporin ...... n in congestive heart failure.
@nl
prefLabel
Urinary excretion of aquaporin ...... n in congestive heart failure.
@en
Urinary excretion of aquaporin ...... n in congestive heart failure.
@nl
P2093
P1433
P1476
Urinary excretion of aquaporin ...... n in congestive heart failure.
@en
P2093
Akio Yoshimura
Hiroshi Funayama
Masanobu Kawakami
Muneyasu Saito
San-E Ishikawa
Takako Saito
Tomohiro Nakamura
P304
P356
10.1111/J.1523-1755.2004.00902.X
P407
P577
2004-10-01T00:00:00Z
P5875
P6179
1027356628